GBIPharma
Home About_us Product Services Events contact_us
HOME > News  
news
 
Friday, July 30, 2010
  • Henan health officials visit UK as part of joint HIV/AIDS collaboration
  • MOH holds symposium on increasing hospital workplace security and safety
  • Liaoning releasing revised provincial reimbursement drug list
  • Jinan cautiously adds private facilities to rural health system
  •  
     
    Thursday, July 29, 2010
  • On-line central drug procurement set for 30day roll-out in Heilongjiang
  • Kangmei Pharmaceutical plans Sichuan TCM investments of RMB 600 million
  • Leo Pharmaceutical recalls IV antibiotic product in China
  • HCV is China’s main focus on World Hepatitis Day
  • Major foreign CT/MRI OEMs see large China potential, despite obstacles
  • Qinghai health department in gear to help earthquake reconstruction
  •  
     
    Wednesday, July 28, 2010
  • Novartis signs artimether API purchase agreement with Kunming Pharma
  • Doctors make mouse calls: Beijing hospital launches pilots access system
  • SFDA continues to target illegal drug/device advertising
  • Close fitting genes- Affymetrix to launch China specific SNP microarray
  • MSD-Sinopharm marketing partnership seems likely
  •  
     
    Tuesday, July 27, 2010
  • RDPAC raises strong objection to NRDC drug pricing draft measures
  • Beijing municipal health bureau releases rosy reform rollout report
  • Pain, pain, go away- high tech anesthesia center set up in Guangdong
  • Nanjing Tongrentang plans RMB 600 infrastructure investment
  • Major counterfeit drug ring busted, bogus abatacept among products
  •  
     
    Monday, July 26, 2010
  • MOH announcement re-emphasizes rural health improvements and coverage
  • Renminbi-ology: Biotech Billionaire list published
  • New retail pharmacy to focus on premium branded drugs
  • SFDA calls attention to lamivudine and telbivudine ADRs
  •  
     
    Friday, July 23, 2010
  • Insect-borne disease project takes wing in Yunnan
  •  
     
    Copyright © 2010 GB GROUP LIMITED. ALL RIGHTS RESERVED.